Harnessing Machine Learning to accurately predict effectiveness of cancer treatments
Task
Our partnership with GenomiQa will drive the development of predictive analysis tools to enhance patient care. Initial areas of collaboration will include developing improved models to predict how individual patients are likely to respond to various cancer treatments. This ground-breaking partnership puts Max Kelsen and Australia at the global forefront of integrating whole-genome sequencing and AI into clinical practice.
